Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2001 Sep-Oct;3(5):420-7.
doi: 10.1038/sj.neo.7900186.

VEGF-A, VEGF-C, and VEGF-D in colorectal cancer progression

Affiliations
Comparative Study

VEGF-A, VEGF-C, and VEGF-D in colorectal cancer progression

M L George et al. Neoplasia. 2001 Sep-Oct.

Abstract

We aimed to assess the relationship of the angiogenic cytokines VEGF-A, VEGF-C, and VEGF-D and their receptors VEGFR-2 and VEGFR-3 in the adenoma-carcinoma sequence and in metastatic spread of colorectal cancer (CRC). mRNA expression levels were measured using semi-quantitative reverse transcription polymerase chain reaction in 70 CRC (35 with paired mucosae) and 20 adenomatous polyps. Immunohistochemistry and ELISA assessed protein expression. VEGF-D mRNA expression was significantly lower in both polyps and CRCs compared with normal mucosa (P=.0002 and.002, respectively), whereas VEGF-A and VEGF-C were significantly raised in CRCs (P=.006 and.004, respectively), but not polyps (P=.22 and P=.5, respectively). Receptor expression was similar in tumor tissue and normal mucosae. Tumors with lymph node metastases had significantly higher levels of VEGF-A compared with non-metastatic tumors (P=.043). There was no association between VEGF-C or VEGF-D and lymphatic spread. The decrease in VEGF-D occurring in polyps and carcinomas may allow the higher levels of VEGF-A and VEGF-C to bind more readily to the VEGF receptors, and produce the angiogenic switch required for tumor growth. Increased expression of VEGF-A within CRCs was associated with lymphatic metastases, and therefore, this member of the VEGF family may be the most important in determining metastatic spread.

PubMed Disclaimer

Figures

Figure 1
Figure 1
(A) Comparison of corrected VEGF-D protein ratios in colorectal cancers and paired normal mucosa (horizontal bar represents median). (B) Correlation of corrected VEGF-D protein ratios with RT-PCR products (r= 0.36, P=.03).
Figure 2
Figure 2
VEGF-D RT-PCR products of five paired tumors (T) and paired normal mucosa (N).
Figure 3
Figure 3
mRNA expression of VEGF-A, VEGF-C, and VEGF-D through the adenoma-carcinoma sequence. Median values with interquartile range (box) and range (whiskers).
Figure 4
Figure 4
Scatter plot of mRNA expression in normal mucosa, node-negative, and node-positive tumors (horizontal bar represents median).
Figure 5
Figure 5
(A–D) Immunostaining of tumor cytoplasm with VEGF-A (A), VEGF-C (B), VEGF-D (C), and tumour endothelial cells with VEGFR-3 (indicated by black arrow) (D).

References

    1. Folkman J. What is the evidence that tumors are angiogenesis-dependent? J Natl Cancer Inst. 1990;82:4–6. - PubMed
    1. Hanahan D, Folkman J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell. 1996;86:353–364. - PubMed
    1. Wei MH, Popescu NC, Lerman MI, Merrill MJ, Zimonjic DB. Localization of the human vascular endothelial growth factor gene, VEGF, at chromosome 6p12. Hum Genet. 1996;97:794–797. - PubMed
    1. Dvorak HF, Brown LF, Detmar M, Dvorak AM. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am J Pathol. 1995;146:1029–1039. - PMC - PubMed
    1. Houck KA, Leung DW, Rowland AM, Winer J, Ferrara N. Dual regulation of vascular endothelial growth factor bioavailability by genetic and proteolytic mechanisms. J Biol Chem. 1992;267:26031–26037. - PubMed

Publication types

MeSH terms

Substances